Latest Videos Archives

Intermediate-Risk NMIBC/BCG Naïve: Treatment of Choice

Leonard G. Gomella, MD, FACS, explores bladder cancer treatment, particularly in the context of intermediate-risk, BCG-naïve disease.

Posted by Jay Simhan, MD, FACS | May 2025

Jay Simhan, MD, FACS, examines the challenges of penile implants in patients with refractory erectile dysfunction and Peyronie’s disease.

Michael A. O’Donnell, MD, discusses BCG’s role as the standard treatment for non-muscle invasive bladder cancer (NMIBC).

Posted by Ariana L. Smith, MD | Apr 2025

Ariana L. Smith, MD, highlights the achievements of the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium.

Posted by Yair Lotan, MD | Apr 2025

Yair Lotan, MD, discusses urinary biomarkers and highlights their evolving role in bladder cancer detection and surveillance.